...and why meaningful conversation is dying out ...
AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for the combination regimen of VENCLEXTA® (venetoclax) and ...
TDC's Jamie Gray, Elders' Scott Altschwager with clients Gary and Ryan Bowyer, Powerscourt Pastoral, Robe who bought the ...